Home›Search›Stem Cell Reviews and Reports

Stem Cell Reviews and Reports

Springer · United States · Est. 2011

ISSN2629-3269eISSN2629-3277

SJR Q2✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

1.217

H-Indexi

SNIPi

0.861

Total Worksi

1,215

Total Citationsi

19,679

2yr Mean Citednessi

3.59

Open Impact Factor alternative

Aims & Scope

Stem Cell Reviews and Reports covers contemporary and emerging areas in stem cells and regenerative medicine through the publication of reviews, original data reports (full reports and short reports), protocols, novel hypotheses and commentaries. The scope related to stem cells is broad and includes topics in stem cell biology covering basic, clinical, biotechnology, regulatory, and ethical aspects of embryonic and adult stem cells, induced pluripotent stem cells, fate choice, specific lineage and cloning issues, translational studies, and diseases where stem cell anomalies play a key role and related matters. Original articles are expected to provide novel insights based on new data. Reviews, commentaries and hypotheses should provide syntheses of current concepts in the field and discuss emerging issues and controversies; the nature of the topic or idea being discussed will dictate appropriate choice of article type. Protocols will help accelerate studies in the field, by providing practical and step by step descriptions of established or emerging protocols and techniques of utility for both established and novice investigator. Stem Cells Reviews and Reports is proud to announce a new Topical Collection Translational Medicine and Biomarkers, now welcoming papers for consideration by Dr. Yanis Berkane, Section Editor. See the complete list of our journal’s Special Issues and Topical Collections here, all currently welcoming papers for consideration.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2011

FrequencyBimonthly, 2013-

StatusActive (last: 2026)

Total Publications1,215

Publisher OrgSpringer Nature

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Springer

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2629-3269 / 2629-3277

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

3.2k

2019

148

5.3k

2020

211

4.9k

2021

188

3.8k

2022

179

2.2k

2023

159

1.5k

2024

208

687

2025

175

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ2

Cell BiologyQ2

Subject Classification

Web of Science Categories

Cell & Tissue EngineeringCell BiologyMedicine, Research & Experimental

Scopus Categories

Cancer ResearchCell Biology

Research Topics (OpenAlex)

Mesenchymal stem cell researchPluripotent Stem Cells ResearchTissue Engineering and Regenerative MedicineExtracellular vesicles in diseaseMicroRNA in disease regulationHematopoietic Stem Cell TransplantationCancer Cells and Metastasis3D Printing in Biomedical ResearchCRISPR and Genetic EngineeringNeurogenesis and neuroplasticity mechanisms

Frequently asked questions about Stem Cell Reviews and Reports

Is Stem Cell Reviews and Reports a predatory journal?

PubScope has no integrity flags on record for Stem Cell Reviews and Reports: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Stem Cell Reviews and Reports?

Stem Cell Reviews and Reports is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.59.

Is Stem Cell Reviews and Reports indexed in Scopus and Web of Science?

Stem Cell Reviews and Reports is indexed in Web of Science, Scopus.